Emergent BioSolutions Inc (FRA:ER4)
€ 5.57 -0.242 (-4.16%) Market Cap: 301.09 Mil Enterprise Value: 1.07 Bil PE Ratio: 0 PB Ratio: 0.49 GF Score: 74/100

Q1 2020 Emergent BioSolutions Inc Earnings Call Transcript

Apr 30, 2020 / 09:00PM GMT
Release Date Price: €68.5 (+0.74%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Q1 2020 Emergent BioSolutions Earnings Conference Call. (Operator Instructions) Please be advised that today's conference call may be recorded.

I would now like to hand the conference over to the company for opening remarks.

Robert G. Burrows
Emergent BioSolutions Inc. - VP of IR

Thank you, Valerie, and good afternoon, everyone. My name is Bob Burrows. I'm Vice President of Investor Relations for Emergent, and thank you for joining us today as we discuss the operational and financial results for the first quarter of 2020. As is customary, today's call is open to all participants, and in addition, the call is being recorded and is copyrighted by Emergent BioSolutions.

The agenda for today's call will be a slight modification to our normal approach. Participating on the call with prepared comments will be Bob Kramer, President and Chief Executive Officer, and Rich Lindahl, Chief Financial Officer. However, in acknowledgement to recent announcements from the company, in between

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot